Since increased systemic iron is associated with the risk of type-2-diabetes, further studies were directed at whether PrP-mediated change in pancreatic β-cell iron influences insulin production and/or secretion and blood glucose levels. This evidence concerns the gene INS and type 2 diabetes mellitus.